Women’s Voices for the Earth is inclined to disagree that “particle/droplet size data under consumer use conditions are rarely needed when assessing the inhalation safety of an ingredient in a spray cosmetic product,” as stated in a draft resource document currently under revision by Cosmetic Ingredient Review. The group’s Expert Panel will consider the matter Dec. 3-4 in Washington.
Cosmetic Ingredient Review and Women’s Voices for the Earth still seem to be on different pages regarding an appropriately protective, science-based framework for assessing the safety of aerosol products/ingredients, a topic up for discussion at the CIR Expert Panel’s Dec. 3-4 meeting in Washington.
CIR is in the process of revising its Aerosols Precedent document, intended as a backgrounder on evaluating the safety of...
Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.
The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”
Bayer's Iberogast Advance's combination of six herbal ingredients may produce a synergistic effect that acts on multiple underlying issues contributing to digestive disorders like functional dyspepsia (FD) and irritable bowel syndrome (IBS), a recently published study suggests.
Effective date for ACNU OTC switch final rule and finding of severe itching from long-term use of common allergy ingredients are bookends for limits of FDA’s authority for product label changes.
P&G provided sufficient support for all challenged claims, including the “Gum Detoxify” brand used on the product label and in advertising on the website and in magazine detail pages.
Available in French pharmacies and online, ValbiotisPRO Cardio-circulation comprises a blend of six plant extracts and is targeted at those with high blood pressure.
L’Oréal SA and NVIDIA Corp. are collaborating to unlock AI’s potential access across beauty, including innovation, scalability, and personalized marketing, the French beauty firm and the tech company announced during the Viva Technology show in Paris.
